Delivery Order SPE2DB22D3016-SPE2DB25FBEK4
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract utilizes firm fixed price terms with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 8, 2025, valued at $21,820.23 for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively small transaction within...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,989.90 by the Defense Logistics Agency (DLA) on July 14, 2025. The order is for Prevnar 20 vaccine in 0.5ml syringes and will be completed by July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,633.77 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 16, 2025, for the supply of PREVNAR 20 syringes (0.5 mL) valued at $32,675.40. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The award is funded through the Medical Supply Chain, a defense-oriented federal agency responsible for procurement of medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,475.11 by the Defense Logistics Agency (DLA) for the supply of PREVNAR 20 syringes (0.5 mL). The contract, issued as a firm fixed price delivery order without set-aside designation, was competitively awarded and became effective on May 20, 2025, with an ultimate completion date of May 21, 2025. Performance will take place at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract, valued at $98,026.20 with a firm fixed price structure, is scheduled for completion by August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, PA 19428. This is a competitively awarded,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $32,370.91 by the Defense Logistics Agency on June 26, 2025, for the supply of PREVNAR 20 syringe (0.5mL) vaccine product. The contract employs firm fixed pricing and is set to be completed by June 27, 2025. This delivery order is non-competitive, indicating it was issued under an existing contract vehicle rather than through open solicitation. This award is issued as a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 3, 2025, for PREVNAR 20 Syringe 0.5ML with a ceiling value of $40,502.71. This firm fixed-price delivery order is set to be completed by September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, PA. The award represents a competitive procurement with no set-aside...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEK4Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,401.39 by the Defense Logistics Agency (DLA) on August 8, 2025. The contract, designated as 4569035711, covers the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The company's track record of fulfilling federal medical procurement requirements through multiple therapeutic domains demonstrates its capability to serve as a critical vendor for Defense Department healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 8/8/25 |